Proliferation and apoptosis before and after radiochemotherapy in rectal cancer;Proliferation und Apoptose vor und nach praoperativer simultaner Radiochemotherapie von Rektumkarzinomen

Strahlentherapie und Onkologie

Volumn 174, Issue 6, 1998, Pages 295-299

  Tannapfel, Andrea ^a,e   Nüßlein, Siegfried ^b   Katalinic, Alexander ^b   Köckerling, Ferdinand ^c   Wittekind, Christian ^a   Fietkau, Rainer ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Apoptosis; p53; Proliferation; Radiochemotherapy; Rectal cancer

Indexed keywords

PROTEIN P53;

APOPTOSIS; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031797561     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03038542     Document Type: Review

References (17)

1. Ansari B, Coates PJ, Greenstein BD, et al. In situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993;170:1-8.
2. Carson DA, Lois A. Cancer progression and p53. Lancet 1995;46:1009-11.
3. D'Amico AV, McKenna WG. Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother Oncol 1994;33:3-10.
4. Dunst J, Sauer R. Adjuvante Therapie des Rektumkarzinoms. Aktueller Stand. Strahlenther Onkol 1994;170:375-82.
5. Dunst J. Dauerinfusion versus Bolusgabe von 5-FU bei adjuvanter Radiochemotherapie des Rektumkarzinoms. Strahlenther Onkol 1994; 170:56-7.
6. Elledge RM, Lee WH. Life and death by p53. Bioessays 1995;17:923-30.
7. Fisher DE. Apoptosis in cancer therapy: Crossing the threshold. Cell 1994;78:539-42.
8. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25.
9. Hall PA, Coates PJ, Ansari B, et al. Regulation of cell number in the mammalian gastro-intestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3569-77.
10. Harris CC, Holstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-27.
11. Keilholz L, Dworak O, Dunst J, et al. Präoperative Radiochemotherapie bei primär inoperablen Rektumkarzinomen. Strahlenther Onkol 1995; 171:70-6.
12. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer-therapy. Cancer 1994;73:2013-26.
13. Ling CC, Guo M, Chen CH, et al. Radiation-induced apoptosis: effects of cell age and dose fractionation. Cancer Res 1995;55:5207-12.
14. Lowe SW, Ruley HE. Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes Dev 1993;7: 535-45.
15. Lowe SW, Ruley HE, Jacks T, et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
16. Tannapfel A, Hahn H, Katalinic A, et al. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 1996;77:164-71.
17. Tannapfel A, Hahn H, Katalinic A, et al. Incidence of apoptosis, cell proliferation and p53 expression in renal cell carcinomas. Anticancer Res 1997;17:1155-62.